Cycrimine

Source: Wikipedia, the free encyclopedia.
Cycrimine
Clinical data
License data
ATC code
  • none
Identifiers
  • 1-Cyclopentyl-1-phenyl-3-(piperidin-1-yl)propan-1-ol
JSmol)
  • OC(CCN1CCCCC1)(C2CCCC2)c3ccccc3
  • InChI=1S/C19H29NO/c21-19(18-11-5-6-12-18,17-9-3-1-4-10-17)13-16-20-14-7-2-8-15-20/h1,3-4,9-10,18,21H,2,5-8,11-16H2
  • Key:SWRUZBWLEWHWRI-UHFFFAOYSA-N

Cycrimine (trade name Pagitane) is a central anticholinergic drug designed to reduce the levels of acetylcholine in the treatment of Parkinson's disease. Its mechanism of action is to bind to the muscarinic acetylcholine receptor M1.[1]

Synthesis

Cycrimine synthesis:[2]

See also

References

External links